GlassScriptPhysician profile
Laura E Stockamp
NPI 1457713687
$2,812.10
in general payments reported to CMS, 2019-2025
10 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $412 · 2023: $1,210 · 2024: $618 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,281.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $813.18 | 2022-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Abbott Laboratories | $570.92 | 2021-2024 | Mitraclip, Epic |
| Abiomed | $398.05 | 2023-2024 | Impella |
| W. L. Gore & Associates, INC. | $302.81 | 2023-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Edwards Lifesciences Corporation | $259.36 | 2022-2023 | |
| Davol INC. | $154.58 | 2023 | Tridyne Vascular Sealant |
| Kci USA, INC. | $101.60 | 2023 | Prevena |
| Amgen INC. | $100.15 | 2023 | Repatha |
| Helios Cardio INC | $88.45 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $23.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Stockamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.